Skip to main content

Breyanzi Prices, Coupons and Patient Assistance Programs

Breyanzi (lisocabtagene maraleucel) is a member of the miscellaneous antineoplastics drug class and is commonly used for B Cell Lymphoma, and Diffuse Large B-Cell Lymphoma.

Breyanzi prices

The cost for Breyanzi intravenous suspension - is around $432,055 for a supply of 1 suspension, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Breyanzi price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Intravenous Suspension Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Breyanzi Coupons and Rebates

Breyanzi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Breyanzi Cell Therapy 360 Program: Eligible commercially insured patients receive financial assistance when enrolled in this program; for additional information contact the program at 888-805-4555.

Applies to:
Number of uses:
Per prescription per year

Form more information phone: 888-805-4555 or Visit website

Patient Assistance Programs for Breyanzi

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Breyanzi (lisocabtagene maraleucel) Injection; IV infusion

More information please phone: 866-316-7263 Visit Website

Provider: Cell Therapy 360

Elligibility requirements:
  1. Determined case by case
  2. At or below 600% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be residing in the US.
  5. Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Breyanzi (lisocabtagene maraleucel) Injection; IV infusion

More information please phone: 888-805-4555 Visit Website